Amneal Pharmaceuticals Competitors and Similar CompaniesClear all
Amneal Pharmaceuticals's competitors and similar companies include Shionogi, Sun Pharma and Spirovant Sciences.
 Amneal Pharmaceuticals Amneal Pharmaceuticals is a company engaged in the development, manufacturing, and distribution of generic and specialty pharmaceutical products. |  Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. |  Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company. |  Spirovant Sciences Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases. | |
Founding Date | Founding Date 2002 | Founding Date 1878 | Founding Date 1983 | Founding Date 2016 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Bridgewater Township, US HQ Gröbenzell, DE Ahmedabad, IN Ahmedabad, IN Ahmedabad, IN Dahej, IN Mahabubnagar, IN see more | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more | Locations Philadelphia, US HQ |
Employees | Employees 8,1005% increase | Employees 4,955 | Employees 43,000 | Employees 234% decrease |
Valuation ($) | Valuation ($) 2.6 b | Valuation ($) 12.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $3b (FY, 2025) | Revenue (est.) ¥499.7b (FY, 2026) | Revenue (est.) ₹582.2b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods $1.9b (FY, 2025) | Cost of goods ¥62.1b (FY, 2026) | Cost of goods ₹115.4b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit $1.1b (FY, 2025) | Gross profit ¥484.8b (FY, 2026) | Gross profit ₹488.9b (FY, 2026) | Gross profit N/A |
Net income | Net income $127.9m (FY, 2025) | Net income ¥205.9b (FY, 2026) | Net income ₹115.6b (FY, 2026) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Shionogi
HQ
Osaka, JP
Employees
4,955
Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.
View companySun Pharma
HQ
Mumbai, IN
Employees
43,000
Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.
View companySpirovant Sciences
HQ
Philadelphia, US
Employees
23↓ 4% decrease
Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases.
View company